Enzalutamide treatment for the whole spectrum of CRPC. Issue 11 (November 2018)
- Record Type:
- Journal Article
- Title:
- Enzalutamide treatment for the whole spectrum of CRPC. Issue 11 (November 2018)
- Main Title:
- Enzalutamide treatment for the whole spectrum of CRPC
- Authors:
- Zhao, Hanson
Freedland, Stephen - Abstract:
- The FDA recently expanded the indication for enzalutamide for the treatment of all men with metastatic and nonmetastatic castration-resistant prostate cancer on the basis of the PROSPER trial. Now that both disease states can have the same treatment, the need to thoroughly identify metastatic lesions is questioned.
- Is Part Of:
- Nature reviews. Volume 15:Issue 11(2018)
- Journal:
- Nature reviews
- Issue:
- Volume 15:Issue 11(2018)
- Issue Display:
- Volume 15, Issue 11 (2018)
- Year:
- 2018
- Volume:
- 15
- Issue:
- 11
- Issue Sort Value:
- 2018-0015-0011-0000
- Page Start:
- 663
- Page End:
- 665
- Publication Date:
- 2018-11
- Subjects:
- Urology -- Periodicals
Clinical medicine -- Periodicals
Urology -- Diseases -- Diagnosis -- Periodicals
Urology -- Diseases -- Treatment -- Research -- Periodicals
616.6005 - Journal URLs:
- http://www.nature.com/nrurol/index.html ↗
http://www.nature.com/ ↗ - DOI:
- 10.1038/s41585-018-0090-1 ↗
- Languages:
- English
- ISSNs:
- 1759-4812
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6047.240000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11055.xml